Valuation: Sanofi

Market Cap 88.14B 98.91B 81.6B 73.85B 139B 9,334B 141B 978B 384B 4,906B 371B 363B 15,634B P/E 2026 *
11.7x
P/E 2027 * 10.1x
Enterprise Value 99.48B 112B 92.1B 83.35B 157B 10,535B 159B 1,104B 433B 5,537B 419B 410B 17,645B EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.9x
Free-Float
88.34%
Yield 2026 *
5.8%
Yield 2027 * 6.13%
1 day-1.04%
1 week+3.02%
Current month-0.63%
1 month-3.60%
3 months-6.35%
6 months-13.07%
Current year-15.46%
1 week 39.5
Extreme 39.505
41.54
1 month 39.07
Extreme 39.07
41.96
Current year 39.07
Extreme 39.07
49.42
1 year 39.07
Extreme 39.07
52.68
3 years 39.07
Extreme 39.07
60.12
5 years 36.91
Extreme 36.91
60.12
10 years 36.81
Extreme 36.8101
60.12
Manager TitleAgeSince
Chief Executive Officer 65 2026-04-30
Director of Finance/CFO 64 2024-03-31
Chief Tech/Sci/R&D Officer - 2026-08-31
Director TitleAgeSince
Director/Board Member 61 2019-04-29
Director/Board Member 56 2020-04-27
Director/Board Member 65 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%+3.02% - - 98.91B
-1.01%+5.13%+58.93%+117.36% 1,133B
-0.61%+1.52%+34.34%+68.48% 621B
-1.48%+0.47%+23.08%+94.76% 503B
+0.54%+5.69%+39.60%+64.02% 379B
+1.07%+1.70%+71.06%+45.98% 370B
+0.30%+3.44%+21.35%+49.62% 292B
-0.03%+2.55%+1.12%+20.94% 262B
-0.14%+2.87%+45.56%+57.22% 237B
-1.88%+0.02%+23.77%+97.39% 190B
Average -0.14%+3.22%+35.42%+68.42% 443.11B
Weighted average by Cap. +0.30%+3.73%+40.84%+79.37%

Financials

2026 *2027 *
Net sales 47.56B 53.38B 44.04B 39.85B 75.08B 5,037B 75.97B 528B 207B 2,648B 200B 196B 8,437B 50.67B 56.87B 46.92B 42.46B 79.99B 5,366B 80.94B 563B 221B 2,821B 213B 209B 8,988B
Net income 7.67B 8.61B 7.1B 6.43B 12.11B 812B 12.25B 85.14B 33.41B 427B 32.29B 31.62B 1,361B 9.07B 10.18B 8.4B 7.6B 14.32B 961B 14.49B 101B 39.52B 505B 38.2B 37.4B 1,609B
Net Debt 11.34B 12.72B 10.5B 9.5B 17.9B 1,201B 18.11B 126B 49.38B 631B 47.73B 46.73B 2,011B 8B 8.98B 7.41B 6.71B 12.64B 848B 12.79B 88.85B 34.86B 446B 33.7B 33B 1,420B
Projected Income Statement - Annual - Sanofi
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
26-10-21 US$40.97 -1.04% 3,110,594
26-10-20 US$41.40 +4.62% 4,241,467
26-10-19 US$39.57 -2.56% 3,619,866
26-10-16 US$40.61 +0.79% 4,631,926
26-10-15 US$40.29 +1.31% 5,053,610
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Sanofi
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
73.57EUR
Average target price
93.35EUR
Spread / Average Target
+26.89%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sanofi